Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

Under the terms of the deal, ACELYRIN shareholders will receive 0.4274 shares of Alumis common stock for each share of ACELYRIN common stock. Once the deal closes, Alumis stockholders will own about ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...

The successful financings come amid a more than two-year stretch when the sector has struggled to attract fresh capital with ...

BioSpace Senior Editor Annalee Armstrong headed to the J.P. Morgan Healthcare Conference with a months-long story idea ...

Vor Biopharma Inc., a biotechnology firm specializing in biological products, has announced a significant adjustment to the exercise prices of certain stock options. On Monday, the company's board of ...

Quantum BioPharma Ltd (NASDAQ:QNTM) shares are rising Tuesday after the company announced positive clinical trial results for ...

BioPharma Ltd. (NASDAQ: QNTM) surged 95% following the announcement of positive results from its clinical trial for the ...

Coeptis also recently acquired NextGenAI and formed a technology division. Wexford-based biopharmaceutical company Coeptis Therapeutics Holdings Inc announced that it would drop the Therapeutics ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...

U.S. Rep. April McClain Delaney visited Kite, a biopharmaceutical company that uses cell therapy to treat cancer, in Urbana on Thursday morning, one of several locations across her district she ...

The biopharma industry is highly dynamic and competitive. Companies that succeed in it must be able to tackle various aspects, including finances, marketing, regulations, investor relations, ...